LORD, ABBETT & CO. LLC - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 164 filers reported holding CLOVIS ONCOLOGY INC in Q4 2015. The put-call ratio across all filers is 0.74 and the average weighting 0.3%.

Quarter-by-quarter ownership
LORD, ABBETT & CO. LLC ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q4 2017$13,132,000
-44.0%
193,117
-32.1%
0.04%
-45.6%
Q3 2017$23,448,000
-56.8%
284,565
-50.9%
0.07%
-57.8%
Q2 2017$54,249,000
+41.0%
579,397
-4.1%
0.16%
+40.0%
Q1 2017$38,466,000
+334.3%
604,157
+203.0%
0.12%
+325.9%
Q4 2016$8,856,000
+89.2%
199,373
+53.5%
0.03%
+92.9%
Q3 2016$4,681,000
-78.2%
129,854
-44.4%
0.01%
-78.5%
Q3 2015$21,470,000
-70.0%
233,469
-71.3%
0.06%
-65.6%
Q2 2015$71,546,000
+68.8%
814,128
+42.6%
0.19%
+76.6%
Q1 2015$42,391,000
+36.5%
571,080
+3.0%
0.11%
+35.4%
Q4 2014$31,046,000
+204.4%
554,395
+125.1%
0.08%
+558.3%
Q2 2014$10,200,000
+0.2%
246,306
+67.7%
0.01%
-47.8%
Q1 2014$10,175,000
-57.1%
146,890
-62.7%
0.02%
-56.6%
Q4 2013$23,726,000
+30.2%
393,659
+31.3%
0.05%
+26.2%
Q3 2013$18,221,000
-17.4%
299,794
-9.0%
0.04%
-17.6%
Q2 2013$22,066,000329,4410.05%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q4 2015
NameSharesValueWeighting ↓
Versant Venture Management, LLC 814,833$60,485,054,00053.20%
Palo Alto Investors LP 2,121,857$157,505,0007.79%
NEA Management Company, LLC 2,279,781$169,228,0007.65%
EcoR1 Capital, LLC 243,048$18,041,0006.01%
Redmile Group, LLC 900,879$66,872,0006.00%
Opaleye Management Inc. 140,000$10,392,0004.82%
PFM Health Sciences, LP 2,266,756$168,261,0004.64%
Partner Investment Management, L.P. 40,798$3,028,0004.56%
CLIFTON PARK CAPITAL MANAGEMENT, LLC 826,919$61,383,0003.74%
Opus Point Partners Management, LLC 55,988$4,156,0003.48%
View complete list of CLOVIS ONCOLOGY INC shareholders